Literature DB >> 9865980

Etiology of respiratory tract infection in adults in a general practice setting.

D Lieberman1, P Shvartzman, D Lieberman1, M Ben-Yaakov, Z Lazarovich, S Hoffman, R Mosckovitz, B Ohana, M Leinonen, D Luffy, I Boldur.   

Abstract

A prospective study was conducted over a 3-month winter period in three general practice clinics in an urban population in southern Israel to identify the etiological agents of respiratory tract infections (RTI) in adults. RTI was defined as an acute febrile illness with cough, coryza, sore throat or hoarseness. Serum samples were taken from all patients in both the acute and convalescent phases of their illness. Tests were conducted for detection of 17 microorganisms known to cause RTI, including serological tests for 16 known pathogens. An etiological diagnosis was established in 80 (66%) of the 122 patients who participated in the study. The distribution of the etiological agents was as follows: influenza B virus in 27 (22%) patients. Chlamydia pneumoniae in 22 (18%), Legionella spp. in 15 (12%), Mycoplasma pneumoniae in 13 (11%), influenza A virus in 11 (9%), Bordetella pertussis in 9 (7%), adenovirus in 4, Epstein Barr virus in 4, Haemophilus influenzae in 3, beta-hemolytic streptococci in 3, Streptococcus pneumoniae in 2, respiratory syncytial virus in 2, parainfluenza 1 virus in 2 and parainfluenza 2 virus in 1. No patients were found to be infected with Coxiella burnetii, Moraxella catarrhalis or parainfluenza 3 virus. More than one pathogen was identified in 27 (34%) patients in whom an etiological diagnosis was established. It is concluded that RTI is caused by a broad spectrum of etiological agents, a considerable number of patients having evidence of infection with more than one pathogen. The therapeutic significance of these findings should be elucidated in further studies.

Entities:  

Mesh:

Year:  1998        PMID: 9865980     DOI: 10.1007/s100960050161

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  19 in total

1.  Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece.

Authors:  A Polyzou; S Pournaras; U Dafni; D Sofianou; E Christeli; S Patrinos; A Tsakris
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

Review 2.  The burden of influenza B: a structured literature review.

Authors:  W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

3.  Prevalence of antibodies to Chlamydia pneumoniae in an Israeli population without clinical evidence of respiratory infection.

Authors:  M Ben-Yaakov; G Eshel; L Zaksonski; Z Lazarovich; I Boldur
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

4.  Estimating the prevalence of coinfection with influenza virus and the atypical bacteria Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae.

Authors:  M J Mina; R M Burke; K P Klugman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-01       Impact factor: 3.267

5.  Respiratory tract infections during the 2011 Mycoplasma pneumoniae epidemic.

Authors:  N Reinton; L Manley; T Tjade; A Moghaddam
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-25       Impact factor: 3.267

6.  Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling.

Authors:  Teruhito Yasui; Micah Luftig; Vishal Soni; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-26       Impact factor: 11.205

7.  Generic versus non-generic formulation of extended-release clarithromycin in patients with community-acquired respiratory tract infections: a prospective, randomized, comparative, investigator-blind, multicentre study.

Authors:  J R Snyman; H S Schoeman; M P Grobusch; M Henning; W Rabie; M Hira; K Parshotam; Y Mithal; S Singh; Z Ramdas
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

8.  Bordetella pertussis in adult pneumonia patients.

Authors:  Kirsten A Beynon; Sheryl A Young; Richard T R Laing; Timothy G Harrison; Trevor P Anderson; David R Murdoch
Journal:  Emerg Infect Dis       Date:  2005-04       Impact factor: 6.883

9.  Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity.

Authors:  Victor I Ayala; John R Teijaro; Donna L Farber; Susan G Dorsey; Nicholas H Carbonetti
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

10.  Managing febrile respiratory illnesses during a hypothetical SARS outbreak.

Authors:  Kamran Khan; Peter Muennig; Michael Gardam; Joshua Graff Zivin
Journal:  Emerg Infect Dis       Date:  2005-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.